HGG Advances (Oct 2024)
LARP1 haploinsufficiency is associated with an autosomal dominant neurodevelopmental disorder
- James Chettle,
- Raymond J. Louie,
- Olivia Larner,
- Robert Best,
- Kevin Chen,
- Josephine Morris,
- Zinaida Dedeic,
- Anna Childers,
- R. Curtis Rogers,
- Barbara R. DuPont,
- Cindy Skinner,
- Sébastien Küry,
- Kevin Uguen,
- Marc Planes,
- Danielle Monteil,
- Megan Li,
- Aviva Eliyahu,
- Lior Greenbaum,
- Nofar Mor,
- Thomas Besnard,
- Bertrand Isidor,
- Benjamin Cogné,
- Alyssa Blesson,
- Anne Comi,
- Ingrid M. Wentzensen,
- Blake Vuocolo,
- Seema R. Lalani,
- Roberta Sierra,
- Lori Berry,
- Kent Carter,
- Stephan J. Sanders,
- Sarah P. Blagden
Affiliations
- James Chettle
- Department of Oncology, University of Oxford, Oxford, UK
- Raymond J. Louie
- Greenwood Genetic Center, Greenwood, SC, USA; Corresponding author
- Olivia Larner
- University of South Carolina School of Medicine Greenville, Greenville, SC, USA
- Robert Best
- University of South Carolina School of Medicine Greenville, Greenville, SC, USA
- Kevin Chen
- Yale University, New Haven, CT, USA
- Josephine Morris
- Department of Oncology, University of Oxford, Oxford, UK
- Zinaida Dedeic
- Department of Oncology, University of Oxford, Oxford, UK
- Anna Childers
- Greenwood Genetic Center, Greenwood, SC, USA
- R. Curtis Rogers
- Greenwood Genetic Center, Greenwood, SC, USA
- Barbara R. DuPont
- Greenwood Genetic Center, Greenwood, SC, USA
- Cindy Skinner
- Greenwood Genetic Center, Greenwood, SC, USA
- Sébastien Küry
- Nantes Université, CHU Nantes, Service de Génétique Médicale, 44000 Nantes, France; Nantes Université, CHU Nantes, CNRS, INSERM, L’institut du thorax, 44000 Nantes, France
- Kevin Uguen
- Service de Génétique Médicale et Biologie de la Reproduction, CHRU de Brest, Brest, France
- Marc Planes
- Service de Génétique Médicale et Biologie de la Reproduction, CHRU de Brest, Brest, France
- Danielle Monteil
- Naval Medical Center Portsmouth, Portsmouth, VA, USA
- Megan Li
- Invitae, San Francisco Corp., San Francisco, CA, USA
- Aviva Eliyahu
- The Danek Gertner Institute of Human Genetics, Sheba Medical Center, Tel Hashomer, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
- Lior Greenbaum
- The Danek Gertner Institute of Human Genetics, Sheba Medical Center, Tel Hashomer, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; The Joseph Sagol Neuroscience Center, Sheba Medical Center, Tel Hashomer, Israel
- Nofar Mor
- The Genomic Unit, Sheba Cancer Research Centre, Sheba Medical Center, Tel Hashomer, Israel
- Thomas Besnard
- Nantes Université, CHU Nantes, Service de Génétique Médicale, 44000 Nantes, France; Nantes Université, CHU Nantes, CNRS, INSERM, L’institut du thorax, 44000 Nantes, France
- Bertrand Isidor
- Nantes Université, CHU Nantes, Service de Génétique Médicale, 44000 Nantes, France; Nantes Université, CHU Nantes, CNRS, INSERM, L’institut du thorax, 44000 Nantes, France
- Benjamin Cogné
- Nantes Université, CHU Nantes, Service de Génétique Médicale, 44000 Nantes, France; Nantes Université, CHU Nantes, CNRS, INSERM, L’institut du thorax, 44000 Nantes, France
- Alyssa Blesson
- Kennedy Krieger Institute, Baltimore, MD, USA
- Anne Comi
- Kennedy Krieger Institute, Baltimore, MD, USA
- Ingrid M. Wentzensen
- GeneDx, Gaithersburg, MD, USA
- Blake Vuocolo
- Baylor College of Medicine, Houston, TX, USA
- Seema R. Lalani
- Baylor College of Medicine, Houston, TX, USA
- Roberta Sierra
- Baylor College of Medicine, Houston, TX, USA
- Lori Berry
- Baylor College of Medicine, Houston, TX, USA
- Kent Carter
- University of Texas Rio Grande Valley, Edinburg, TX, USA
- Stephan J. Sanders
- Institute of Developmental and Regenerative Medicine, Department of Paediatrics, University of Oxford, Oxford, UK; Department of Psychiatry and Behavioral Sciences, UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA
- Sarah P. Blagden
- Department of Oncology, University of Oxford, Oxford, UK; Corresponding author
- Journal volume & issue
-
Vol. 5,
no. 4
p. 100345
Abstract
Summary: Autism spectrum disorder (ASD) is a neurodevelopmental disorder (NDD) that affects approximately 4% of males and 1% of females in the United States. While causes of ASD are multi-factorial, single rare genetic variants contribute to around 20% of cases. Here, we report a case series of seven unrelated probands (6 males, 1 female) with ASD or another variable NDD phenotype attributed to de novo heterozygous loss of function or missense variants in the gene LARP1 (La ribonucleoprotein 1). LARP1 encodes an RNA-binding protein that post-transcriptionally regulates the stability and translation of thousands of mRNAs, including those regulating cellular metabolism and metabolic plasticity. Using lymphocytes collected and immortalized from an index proband who carries a truncating variant in one allele of LARP1, we demonstrated that lower cellular levels of LARP1 protein cause reduced rates of aerobic respiration and glycolysis. As expression of LARP1 increases during neurodevelopment, with higher levels in neurons and astrocytes, we propose that LARP1 haploinsufficiency contributes to ASD or related NDDs through attenuated metabolic activity in the developing fetal brain.